Comment on <scp>COVID</scp>‐19 in patients with myasthenia gravis: Author response
Pria Anand(Boston University), Amanda C. Guidon(Harvard University), Michelle Kaku(Icahn School of Medicine at Mount Sinai), Anna M. Cervantes‐Arslanian(Boston University), Michaël C. C. Slama(Harvard University), Lan Zhou(Hospital for Special Surgery), Charlene Ong(Boston University), William S. David(Massachusetts General Hospital)
Cited by 1
Related Papers
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
|Brain|2020|487
Multimodal deep learning for Alzheimer’s disease dementia assessment
|Nature Communications|2022|390
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
|The Lancet Neurology|2020|121
Newborn infants learn during sleep
|Proceedings of the National Academy of Sciences|2010|118
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes
|The Lancet Neurology|2023|118